Endothelial nitric oxide synthase gene polymorphism in the Indian and Mestizo populations of Mexico

被引:17
作者
Rosas-Vargas, H
Flores-Segura, A
Guizada-Claure, B
Vargas-Alarcón, G
Granados, J
Salamanca, F
Coral-Vázquez, R [1 ]
机构
[1] Ctr Med Nacl Siglo XXI, Hosp Pediat, Unidad Invest Med Genet Humana, Mexico City, DF, Mexico
[2] Inst Nacl Cardiol Ignacio Chavez, Dept Biol Celular, Mexico City, DF, Mexico
[3] Inst Nacl Nutr Salvador Zubiran, Dept Immunol & Rheumatol, Mexico City 14000, DF, Mexico
关键词
NOS polymorphism; Latin America; cardiovascular disease; genet;
D O I
10.1353/hub.2003.0027
中图分类号
Q98 [人类学];
学科分类号
030303 ;
摘要
Endothelium-derived nitric oxide (NO) is an important factor in vasodilation synthesized by endothelial nitric oxide synthase (eNOS). A polymorphism (894 G to T) in exon 7 of the eNOS gene causes the conversion of Glu to Asp in position 298. The Glu298Asp polymorphism has been extensively associated with cardiovascular disease. We determined the Glu298Asp polymorphism frequency in healthy Mexican Mestizo, Huastec, Mayo, and Mayan populations by the endonuclease restriction method. The four populations analyzed were in Hardy-Weinberg equilibrium. Allele frequencies were similar among Mexican populations but different when compared with Caucasians. However, when compared with allele frequencies in Asian populations, Mestizo and Huastec allele frequencies were significantly different. Genotypically, only the Mestizos presented Asp298 homozygosity. The absence of double mutants in Indian populations resembles that in Asians. With these data, we conclude that the low frequency of the eNOS Glu298Asp polymorphism in Indian and Mestizo populations of Mexico is related to the Asian origin of Amerindian groups.
引用
收藏
页码:91 / 96
页数:6
相关论文
共 16 条
[1]   Nitric oxide synthases: structure, function and inhibition [J].
Alderton, WK ;
Cooper, CE ;
Knowles, RG .
BIOCHEMICAL JOURNAL, 2001, 357 (03) :593-615
[2]   The Glu-298→Asp (894G→T) mutation at exon 7 of the endothelial nitric oxide synthase gene and coronary artery disease [J].
Cai, H ;
Wilcken, DEL ;
Wang, XL .
JOURNAL OF MOLECULAR MEDICINE-JMM, 1999, 77 (06) :511-514
[3]   Genes, peoples, and languages [J].
CavalliSforza, LL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (15) :7719-7724
[4]   Acidic hydrolysis as a mechanism for the cleavage of the Glu298 → Asp variant of human endothelial nitric-oxide synthase [J].
Fairchild, TA ;
Fulton, D ;
Fontana, JT ;
Gratton, JP ;
McCabe, TJ ;
Sessa, WC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (28) :26674-26679
[5]  
Gamboa R, 2000, HUM BIOL, V72, P975
[6]   A common variant of the endothelial nitric oxide synthase (Glu298→Asp) is a major risk factor for coronary artery disease in the UK [J].
Hingorani, AD ;
Liang, CF ;
Fatibene, J ;
Lyon, A ;
Monteith, S ;
Parsons, A ;
Haydock, S ;
Hopper, RV ;
Stephens, NG ;
O'Shaughnessy, KM ;
Brown, MJ .
CIRCULATION, 1999, 100 (14) :1515-1520
[7]   Association of the Glu298Asp polymorphism in the endothelial nitric oxide synthase gene with essential hypertension resistant to conventional therapy [J].
Jáchymová, M ;
Horky, K ;
Bultas, J ;
Kozich, V ;
Jindra, A ;
Peleska, J ;
Martásek, P .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 284 (02) :426-430
[8]   A missense mutation of the nitric oxide synthase (eNOS) gene (Glu298Asp) in five patients with coronary artery disease -: Case reports [J].
Liao, YL ;
Saku, K ;
Ou, JF ;
Jimi, S ;
Zhang, B ;
Shirai, K ;
Arakawa, K .
ANGIOLOGY, 1999, 50 (08) :671-676
[9]  
LISKER R, 1990, HUM BIOL, V62, P791
[10]  
MARSDEN PA, 1993, J BIOL CHEM, V268, P17478